Medicine Care Team

Administrative Assistant: Michelle Vitro
Phone: 416-480-6100, ext. 3448
Fax: 416-480-5354
Email: michelle.vitro@sunnybrook.ca
Room: A4 42

Education:

• BA (Hons), Psychology, McGill University, Montreal
• MD (2009), McMaster University, Hamilton
• Neurology residency (2014), University of Toronto, Toronto
• Behavioural neurology/neuropsychiatry fellowship (2015), Harvard Medical School, Massachusetts General Hospital, Boston MA USA
• MPH, (2016) Masters in Public Health, Clinical Effectiveness, Harvard T. H. Chan School of Public Health, Boston, MA USA

Appointments and Affiliations:

• Clinical associate (2015-2016), Sunnybrook Health Sciences Centre
• Staff neurologist (2015-present), Sunnybrook Health Sciences Centre
• Assistant professor (2016-present), Department of Medicine, Division of Neurology, University of Toronto

Research Foci:

• Frontotemporal dementia
• Primary Progressive Aphasia
• Alzheimer’s disease
• Mild Cognitive Impairment
• Neuropsychiatry
• Quality and Innovation in dementia care delivery
• Dementia Care in the acute care hospital

Research/Clinical Profile:

Dr. Mitchell’s academic interests are in the advancement of care for patients with neurodegenerative disease. She has a particular interest in frontotemporal dementia, primary progressive aphasia, mild cognitive impairment, alzheimer’s disease, rapidly progressive dementia and early-onset dementia. She is interested in the advancement of biomarkers and disease modifying treatments in neurodegenerative diseases.

Clinically, she has expertise in the diagnosis and treatment of neurodegenerative diseases. In addition, she has specific interest in the interface between neurology and psychiatry and has advanced training in the field of neuropsychiatry and cognitive/behavioural neurology. She has a defined interest in quality and innovation in dementia care delivery in both the acute care hospital and outpatient setting.

Selected Publications:

• Chee, J.N., Rapoport, M.J., Molnar, F., Herrmann, N., O’Neill, D., Marottoli, R., Mitchell, S., Tant, M., Dow, J., Ayotte, D., Lanctôt, K.L, McFadden, R., Taylor, J.-P., Olsen, K., Classen, S., Elzohairy, Y., Carr, D.B. (Published Online) Update on the Risk of Motor Vehicle Collision or Driving Impairment with Dementia: A Collaborative International Systematic Review and Meta-Analysis. American Journal of Geriatric Psychiatry (Accepted May 11, 2017, Manuscript ID AMGP-17-33R1).
• Gholipour T, Mitchell S, Sarkis RA, Chemali Z. The clinical and neurobehavioural course of Down syndrome and dementia with or without new-onset epilepsy. Epilepsy & Behaviour. March 2017; 68: 11-16 
• Mitchell SB, Lucente D, Larvie M, Cobos MI, Frosch M, & Dickerson BC. A 63-year-old Man With Progressive Visual Symptoms. JAMA Neurology. Jan 2017; 74(1):114-118.
• Mitchell SB, Black, SE. Screening for mild cognitive impairment: If not now, when? CMAJ. Jan 2016: 188 (1): 15-6.
• Goodman, D.W., Mitchell S, Rhodewalt L. & Surman C. B. H. Clinical Presentation, Diagnosis and Treatment of Attention- Deficit Hyperactivity Disorder (ADHD) in Older Adults: A Review of the Evidence and its Implications for Clinical Care. Drugs Aging. Jan 2016; 33(1):27-36.
• Misch, M., Mitchell SB, Francis PL, Sherborn K.. Caldwell CB, Ehrlich L., Lang AE, Black SE, Masellis M. Differentiating between visual hallucination free dementia with Lewy bodies and corticobasal syndrome on the basis of neuropsychology and single-photon emission computed tomorography. Alzheimer's Research & Therapy Dec 2014, 5;6(9):71.